{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:40:47Z","timestamp":1787002847011,"version":"build-2736575974"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SKY2023123"],"award-info":[{"award-number":["SKY2023123"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005144","name":"Basic Research Program of Jiangsu Education Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005144","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cyclic AMP-dependent protein kinase A (PKA) is recognized for its pivotal involvement in various cancer types, with Protein Kinase Inhibitor Beta (PKIB) serving as an endogenous inhibitor that curtails PKA activity. Despite the documented escalation of\n                    <jats:italic>PKIB<\/jats:italic>\n                    expression in several malignancies, a comprehensive understanding of its precise mechanistic implications in human cancers remains elusive. This investigation is centered on bladder cancer (BLCA), unveiling an augmented expression of\n                    <jats:italic>PKIB<\/jats:italic>\n                    concomitant with heightened BLCA cell proliferation, migration, and invasion in vitro and augmented tumorigenic potential in an in vivo model. Mechanistically, PKIB disrupts PKA kinase activity, thereby resulting in diminished phosphorylation of the substrate target protein HSP27 at serine 15, 78, and 82. Additionally, the transcription factor MYCN exhibits an affinity for the\n                    <jats:italic>PKIB<\/jats:italic>\n                    promoter, leading to its enhanced expression in the context of BLCA. These findings reveal the oncogenic proclivity of PKIB and introduce a novel signalling pathway in BLCA, providing valuable insights into potential therapeutic targets for precise intervention.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-07814-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T03:01:10Z","timestamp":1751338870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PKIB facilitates bladder cancer proliferation and metastasis through mediation of HSP27 phosphorylation by PKA"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7136-4299","authenticated-orcid":false,"given":"Xiaolong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7478-7529","authenticated-orcid":false,"given":"Yatfaat","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengding","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5220-7391","authenticated-orcid":false,"given":"Zhe","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2851-3401","authenticated-orcid":false,"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"7814_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrc3983","volume":"15","author":"W Kolch","year":"2015","unstructured":"Kolch W, Halasz M, Granovskaya M, Kholodenko BN. The dynamic control of signal transduction networks in cancer cells. Nat Rev Cancer. 2015;15:515\u201327.","journal-title":"Nat Rev Cancer"},{"key":"7814_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.tcb.2017.09.005","volume":"28","author":"L Gelens","year":"2018","unstructured":"Gelens L, Qian J, Bollen M, Saurin AT. The importance of kinase-phosphatase integration: lessons from mitosis. Trends Cell Biol. 2018;28:6\u201321.","journal-title":"Trends Cell Biol"},{"key":"7814_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1517\/14728220802602349","volume":"13","author":"S Naviglio","year":"2009","unstructured":"Naviglio S, Caraglia M, Abbruzzese A, Chiosi E, Di Gesto D, Marra M, et al. Protein kinase A as a biological target in cancer therapy. Expert Opin Ther Targets. 2009;13:83\u201392.","journal-title":"Expert Opin Ther Targets"},{"key":"7814_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1040-7952(97)80019-5","volume":"31","author":"K Tasken","year":"1997","unstructured":"Tasken K, Skalhegg BS, Tasken KA, Solberg R, Knutsen HK, Levy FO, et al. Structure, function, and regulation of human cAMP-dependent protein kinases. Adv Second Messenger Phosphoprot Res. 1997;31:191\u2013204.","journal-title":"Adv Second Messenger Phosphoprot Res"},{"key":"7814_CR5","doi-asserted-by":"publisher","first-page":"14320","DOI":"10.1073\/pnas.0507072102","volume":"102","author":"AK Howe","year":"2005","unstructured":"Howe AK, Baldor LC, Hogan BP. Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration. Proc Natl Acad Sci USA. 2005;102:14320\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7814_CR6","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1091\/mbc.e08-06-0564","volume":"19","author":"CJ Lim","year":"2008","unstructured":"Lim CJ, Kain KH, Tkachenko E, Goldfinger LE, Gutierrez E, Allen MD, et al. Integrin-mediated protein kinase A activation at the leading edge of migrating cells. Mol Biol Cell. 2008;19:4930\u201341.","journal-title":"Mol Biol Cell"},{"key":"7814_CR7","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.1074\/jbc.M805606200","volume":"284","author":"AA Paulucci-Holthauzen","year":"2009","unstructured":"Paulucci-Holthauzen AA, Vergara LA, Bellot LJ, Canton D, Scott JD, O\u2019Connor KL. Spatial distribution of protein kinase A activity during cell migration is mediated by A-kinase anchoring protein AKAP Lbc. J Biol Chem. 2009;284:5956\u201367.","journal-title":"J Biol Chem"},{"key":"7814_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cellsig.2017.09.011","volume":"40","author":"E Reggi","year":"2017","unstructured":"Reggi E, Diviani D. The role of A-kinase anchoring proteins in cancer development. Cell Signal. 2017;40:143\u201355.","journal-title":"Cell Signal"},{"key":"7814_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40164-020-00191-1","volume":"9","author":"H Zhang","year":"2020","unstructured":"Zhang H, Kong Q, Wang J, Jiang Y, Hua H. Complex roles of cAMP-PKA-CREB signaling in cancer. Exp Hematol Oncol. 2020;9:32.","journal-title":"Exp Hematol Oncol"},{"key":"7814_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4149\/endo_2012_01_3","volume":"46","author":"P Kwiecinska","year":"2012","unstructured":"Kwiecinska P, Ptak A, Wrobel A, Gregoraszczuk EL. Hydroxylated estrogens (2-OH-E2 AND 4-OH-E2) do not activate cAMP\/PKA and ERK1\/2 pathways activation in a breast cancer MCF-7 cell line. Endocr Regul. 2012;46:3\u201312.","journal-title":"Endocr Regul"},{"key":"7814_CR11","doi-asserted-by":"publisher","first-page":"112341","DOI":"10.18632\/oncotarget.22866","volume":"8","author":"S Gong","year":"2017","unstructured":"Gong S, Chen Y, Meng F, Zhang Y, Wu H, Wu F. Roflumilast restores cAMP\/PKA\/CREB signaling axis for FtMt-mediated tumor inhibition of ovarian cancer. Oncotarget. 2017;8:112341\u201353.","journal-title":"Oncotarget"},{"key":"7814_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.canlet.2018.08.002","volume":"435","author":"E Peverelli","year":"2018","unstructured":"Peverelli E, Giardino E, Mangili F, Treppiedi D, Catalano R, Ferrante E, et al. cAMP\/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells. Cancer Lett. 2018;435:101\u20139.","journal-title":"Cancer Lett"},{"key":"7814_CR13","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.2147\/OTT.S164982","volume":"11","author":"S Wang","year":"2018","unstructured":"Wang S, Zhang Z, Qian W, Ji D, Wang Q, Ji B, et al. Angiogenesis and vasculogenic mimicry are inhibited by 8-Br-cAMP through activation of the cAMP\/PKA pathway in colorectal cancer. Onco Targets Ther. 2018;11:3765\u201374.","journal-title":"Onco Targets Ther"},{"key":"7814_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2381-8","volume":"11","author":"K Jiang","year":"2020","unstructured":"Jiang K, Yao G, Hu L, Yan Y, Liu J, Shi J, et al. MOB2 suppresses GBM cell migration and invasion via regulation of FAK\/Akt and cAMP\/PKA signaling. Cell Death Dis. 2020;11:230.","journal-title":"Cell Death Dis"},{"key":"7814_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2020.03.014","volume":"479","author":"F Huang","year":"2020","unstructured":"Huang F, Ma G, Zhou X, Zhu X, Yu X, Ding F, et al. Depletion of LAMP3 enhances PKA-mediated VASP phosphorylation to suppress invasion and metastasis in esophageal squamous cell carcinoma. Cancer Lett. 2020;479:100\u201311.","journal-title":"Cancer Lett"},{"key":"7814_CR16","first-page":"165","volume":"78","author":"TC Chen","year":"1998","unstructured":"Chen TC, Hinton DR, Zidovetzki R, Hofman FM. Up-regulation of the cAMP\/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab Invest. 1998;78:165\u201374.","journal-title":"Lab Invest"},{"key":"7814_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4161\/cbt.80","volume":"1","author":"TC Chen","year":"2002","unstructured":"Chen TC, Wadsten P, Su S, Rawlinson N, Hofman FM, Hill CK, et al. The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells. Cancer Biol Ther. 2002;1:268\u201376.","journal-title":"Cancer Biol Ther"},{"key":"7814_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.lfs.2011.12.010","volume":"90","author":"EY Moon","year":"2012","unstructured":"Moon EY, Lee GH, Lee MS, Kim HM, Lee JW. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1\/Rap1 pathways. Life Sci. 2012;90:373\u201380.","journal-title":"Life Sci"},{"key":"7814_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-36","volume":"13","author":"EA Cho","year":"2014","unstructured":"Cho EA, Kim EJ, Kwak SJ, Juhnn YS. cAMP signaling inhibits radiation-induced ATM phosphorylation leading to the augmentation of apoptosis in human lung cancer cells. Mol Cancer. 2014;13:36.","journal-title":"Mol Cancer"},{"key":"7814_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3858\/emm.2009.41.8.065","volume":"41","author":"YJ Choi","year":"2009","unstructured":"Choi YJ, Kim SY, Oh JM, Juhnn YS. Stimulatory heterotrimeric G protein augments gamma ray-induced apoptosis by up-regulation of Bak expression via CREB and AP-1 in H1299 human lung cancer cells. Exp Mol Med. 2009;41:592\u2013600.","journal-title":"Exp Mol Med"},{"key":"7814_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.632815","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, Sabatini BL. The Kinase Specificity of Protein Kinase Inhibitor Peptide. Front Pharm. 2021;12:632815.","journal-title":"Front Pharm"},{"key":"7814_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41586-022-05575-3","volume":"613","author":"JL Johnson","year":"2023","unstructured":"Johnson JL, Yaron TM, Huntsman EM, Kerelsky A, Song JH, Regev A, et al. An atlas of substrate specificities for the human serine\/threonine kinome. Nature. 2023;613:759.","journal-title":"Nature"},{"key":"7814_CR23","doi-asserted-by":"crossref","unstructured":"Musket A, Moorman JP, Zhang JY, Jiang Y. PKIB, a novel target for cancer therapy. Int J Mol Sci. 2024;25:4664.","DOI":"10.3390\/ijms25094664"},{"key":"7814_CR24","doi-asserted-by":"crossref","unstructured":"Zhang HY, Liu YL, Liu JY, Chen JZ, Wang J, Hua H, et al. cAMP-PKA\/EPAC signaling and cancer: the interplay in tumor microenvironment. J Hematol Oncol. 2024;17:5.","DOI":"10.1186\/s13045-024-01524-x"},{"key":"7814_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbapap.2005.08.024","volume":"1754","author":"SS Taylor","year":"2005","unstructured":"Taylor SS, Kim C, Vigil D, Haste NM, Yang J, Wu J, et al. Dynamics of signaling by PKA. Biochim Biophys Acta. 2005;1754:25\u201337.","journal-title":"Biochim Biophys Acta"},{"key":"7814_CR26","doi-asserted-by":"publisher","first-page":"6637","DOI":"10.1016\/S0021-9258(19)44739-X","volume":"247","author":"CD Ashby","year":"1972","unstructured":"Ashby CD, Walsh DA. Characterization of the interaction of a protein inhibitor with adenosine 3\u2019,5\u2019-monophosphate-dependent protein kinases. I. Interaction with the catalytic subunit of the protein kinase. J Biol Chem. 1972;247:6637\u201342.","journal-title":"J Biol Chem"},{"key":"7814_CR27","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1021\/bi00633a006","volume":"16","author":"JG Demaille","year":"1977","unstructured":"Demaille JG, Peters KA, Fischer EH. Isolation and properties of the rabbit skeletal muscle protein inhibitor of adenosine 3\u2019,5\u2019-monophosphate dependent protein kinases. Biochemistry. 1977;16:3080\u20136.","journal-title":"Biochemistry"},{"key":"7814_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.npep.2005.10.002","volume":"40","author":"GD Dalton","year":"2006","unstructured":"Dalton GD, Dewey WL. Protein kinase inhibitor peptide (PKI): a family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function. Neuropeptides. 2006;40:23\u201334.","journal-title":"Neuropeptides"},{"key":"7814_CR29","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1038\/onc.2009.144","volume":"28","author":"S Chung","year":"2009","unstructured":"Chung S, Furihata M, Tamura K, Uemura M, Daigo Y, Nasu Y, et al. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways. Oncogene. 2009;28:2849\u201359.","journal-title":"Oncogene"},{"key":"7814_CR30","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1177\/1535370216655908","volume":"241","author":"P Dou","year":"2016","unstructured":"Dou P, Zhang D, Cheng Z, Zhou G, Zhang L. PKIB promotes cell proliferation and the invasion-metastasis cascade through the PI3K\/Akt pathway in NSCLC cells. Exp Biol Med (Maywood). 2016;241:1911\u20138.","journal-title":"Exp Biol Med (Maywood)"},{"key":"7814_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.965838","volume":"12","author":"R Wan","year":"2022","unstructured":"Wan R, Yang G, Liu Q, Fu X, Liu Z, Miao H, et al. PKIB involved in the metastasis and survival of osteosarcoma. Front Oncol. 2022;12:965838.","journal-title":"Front Oncol"},{"key":"7814_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00795-011-0565-0","volume":"45","author":"K Dabanaka","year":"2012","unstructured":"Dabanaka K, Chung S, Nakagawa H, Nakamura Y, Okabayashi T, Sugimoto T, et al. PKIB expression strongly correlated with phosphorylated Akt expression in breast cancers and also with triple-negative breast cancer subtype. Med Mol Morphol. 2012;45:229\u201333.","journal-title":"Med Mol Morphol"},{"key":"7814_CR33","first-page":"1264","volume":"21","author":"JB Zhang","year":"2017","unstructured":"Zhang JB, Song W, Wang YY, Liu MG, Sun MM, Liu H. Study on correlation between PKIB and pAkt expression in breast cancer tissues. Eur Rev Med Pharm Sci. 2017;21:1264\u20139.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"7814_CR34","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/carcin\/bgs223","volume":"33","author":"K Dahlman-Wright","year":"2012","unstructured":"Dahlman-Wright K, Qiao Y, Jonsson P, Gustafsson JA, Williams C, Zhao C. Interplay between AP-1 and estrogen receptor alpha in regulating gene expression and proliferation networks in breast cancer cells. Carcinogenesis. 2012;33:1684\u201391.","journal-title":"Carcinogenesis"},{"key":"7814_CR35","first-page":"744","volume":"37","author":"HW Wang","year":"2017","unstructured":"Wang HW, Duan ZJ, Hu SS, Wang S. Expression of cAMP-dependent protein kinase inhibitor beta in colorectal carcinoma and its clinical significance]. Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:744\u20139.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"7814_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"7814_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nrurol.2011.144","volume":"8","author":"SM Prasad","year":"2011","unstructured":"Prasad SM, Decastro GJ, Steinberg GD. Medscape. Urothelial carcinoma of the bladder: definition, treatment and future efforts. Nat Rev Urol. 2011;8:631\u201342.","journal-title":"Nat Rev Urol"},{"key":"7814_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.eururo.2017.03.019","volume":"73","author":"V Fonteyne","year":"2018","unstructured":"Fonteyne V, Ost P, Bellmunt J, Droz JP, Mongiat-Artus P, Inman B, et al. Curative treatment for muscle invasive bladder cancer in elderly patients: a systematic review. Eur Urol. 2018;73:40\u201350.","journal-title":"Eur Urol"},{"key":"7814_CR39","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70:404\u201323.","journal-title":"CA Cancer J Clin"},{"key":"7814_CR40","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3892\/mmr.2014.2054","volume":"9","author":"X Zheng","year":"2014","unstructured":"Zheng X, Ou Y, Shu M, Wang Y, Zhou Y, Su X, et al. Cholera toxin, a typical protein kinase A activator, induces G1 phase growth arrest in human bladder transitional cell carcinoma cells via inhibiting the c-Raf\/MEK\/ERK signaling pathway. Mol Med Rep. 2014;9:1773\u20139.","journal-title":"Mol Med Rep"},{"key":"7814_CR41","doi-asserted-by":"publisher","first-page":"47.e21","DOI":"10.1016\/j.urolonc.2013.06.017","volume":"32","author":"Y Ou","year":"2014","unstructured":"Ou Y, Zheng X, Gao Y, Shu M, Leng T, Li Y, et al. Activation of cyclic AMP\/PKA pathway inhibits bladder cancer cell invasion by targeting MAP4-dependent microtubule dynamics. Urol Oncol. 2014;32:47.e21\u20138.","journal-title":"Urol Oncol"},{"key":"7814_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3892\/ijo.2017.3993","volume":"51","author":"WT Kim","year":"2017","unstructured":"Kim WT, Seo SP, Byun YJ, Kang HW, Kim YJ, Lee SC, et al. Garlic extract in bladder cancer prevention: Evidence from T24 bladder cancer cell xenograft model, tissue microarray, and gene network analysis. Int J Oncol. 2017;51:204\u201312.","journal-title":"Int J Oncol"},{"key":"7814_CR43","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/cm.970290410","volume":"29","author":"DM Morton","year":"1994","unstructured":"Morton DM, Tchao R. Regulation of motility and cytoskeletal organization of rat bladder-carcinoma cells by cyclic-Amp. Cell Motil Cytoskel. 1994;29:375\u201382.","journal-title":"Cell Motil Cytoskel"},{"key":"7814_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.574030","volume":"11","author":"C Liu","year":"2020","unstructured":"Liu C, Ke P, Zhang J, Zhang X, Chen X. Protein kinase inhibitor peptide as a tool to specifically inhibit protein kinase A. Front Physiol. 2020;11:574030.","journal-title":"Front Physiol"},{"key":"7814_CR45","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s00018-009-0086-3","volume":"66","author":"S Kostenko","year":"2009","unstructured":"Kostenko S, Moens U. Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci. 2009;66:3289\u2013307.","journal-title":"Cell Mol Life Sci"},{"key":"7814_CR46","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fgene.2014.00346","volume":"5","author":"M Katsogiannou","year":"2014","unstructured":"Katsogiannou M, Andrieu C, Rocchi P. Heat shock protein 27 phosphorylation state is associated with cancer progression. Front Genet. 2014;5:346.","journal-title":"Front Genet"},{"key":"7814_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/bioinformatics\/btu594","volume":"31","author":"IH Moal","year":"2015","unstructured":"Moal IH, Jim\u00e9nez-Garc\u00eda B, Fern\u00e1ndez-Recio J. CCharPPI web server: computational characterization of protein-protein interactions from structure. Bioinformatics. 2015;31:123\u20135.","journal-title":"Bioinformatics"},{"key":"7814_CR48","doi-asserted-by":"publisher","first-page":"37215","DOI":"10.1074\/jbc.M603622200","volume":"281","author":"C Zheng","year":"2006","unstructured":"Zheng C, Lin Z, Zhao ZJ, Yang Y, Niu H, Shen X. MAPK-activated protein kinase-2 (MK2)-mediated formation and phosphorylation-regulated dissociation of the signal complex consisting of p38, MK2, Akt, and Hsp27. J Biol Chem. 2006;281:37215\u201326.","journal-title":"J Biol Chem"},{"key":"7814_CR49","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000608R","volume":"35","author":"X Wang","year":"2021","unstructured":"Wang X, Chang X, He C, Fan Z, Yu Z, Yu B, et al. ATP5B promotes the metastasis and growth of gastric cancer by activating the FAK\/AKT\/MMP2 pathway. FASEB J. 2021;35:e20649.","journal-title":"FASEB J"},{"key":"7814_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12536","volume":"66","author":"YT Chen","year":"2019","unstructured":"Chen YT, Yang CC, Shao PL, Huang CR, Yip HK. Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway. J Pineal Res. 2019;66:e12536.","journal-title":"J Pineal Res"},{"key":"7814_CR51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1200\/JCO.18.00537","volume":"37","author":"JJ Coen","year":"2019","unstructured":"Coen JJ, Zhang P, Saylor PJ, Lee CT, Wu CL, Parker W, et al. Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil\/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG\/RTOG 0712-A Randomized Phase II Trial. J Clin Oncol. 2019;37:44\u201351.","journal-title":"J Clin Oncol"},{"key":"7814_CR52","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"RK Kelley","year":"2023","unstructured":"Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401:1853\u201365.","journal-title":"Lancet"},{"key":"7814_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106554","volume":"187","author":"J Liu","year":"2023","unstructured":"Liu J, Jing W, Wang T, Hu Z, Lu H. Functional metabolomics revealed the dual-activation of cAMP-AMP axis is a novel therapeutic target of pancreatic cancer. Pharm Res. 2023;187:106554.","journal-title":"Pharm Res"},{"key":"7814_CR54","doi-asserted-by":"crossref","unstructured":"Okuno M, Adachi S, Kozawa O, Shimizu M, Yasuda I. The clinical significance of phosphorylated heat shock protein 27 (HSPB1) in pancreatic cancer. Int J Mol Sci. 2016;17:137.","DOI":"10.3390\/ijms17010137"},{"key":"7814_CR55","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1074\/jbc.274.10.6381","volume":"274","author":"JC Wiley","year":"1999","unstructured":"Wiley JC, Wailes LA, Idzerda RL, McKnight GS. Role of regulatory subunits and protein kinase inhibitor (PKI) in determining nuclear localization and activity of the catalytic subunit of protein kinase A. J Biol Chem. 1999;274:6381\u20137.","journal-title":"J Biol Chem"},{"key":"7814_CR56","doi-asserted-by":"publisher","first-page":"15013","DOI":"10.1074\/jbc.C400575200","volume":"280","author":"H Doppler","year":"2005","unstructured":"Doppler H, Storz P, Li J, Comb MJ, Toker A. A phosphorylation state-specific antibody recognizes Hsp27, a novel substrate of protein kinase D. J Biol Chem. 2005;280:15013\u20139.","journal-title":"J Biol Chem"},{"key":"7814_CR57","doi-asserted-by":"publisher","first-page":"14721","DOI":"10.1016\/S0021-9258(18)98746-6","volume":"266","author":"M Gaestel","year":"1991","unstructured":"Gaestel M, Schroder W, Benndorf R, Lippmann C, Buchner K, Hucho F, et al. Identification of the phosphorylation sites of the murine small heat shock protein hsp25. J Biol Chem. 1991;266:14721\u20134.","journal-title":"J Biol Chem"},{"key":"7814_CR58","doi-asserted-by":"publisher","first-page":"9176","DOI":"10.1016\/S0021-9258(17)37091-6","volume":"269","author":"J Cairns","year":"1994","unstructured":"Cairns J, Qin S, Philp R, Tan YH, Guy GR. Dephosphorylation of the small heat shock protein Hsp27 in vivo by protein phosphatase 2A. J Biol Chem. 1994;269:9176\u201383.","journal-title":"J Biol Chem"},{"key":"7814_CR59","doi-asserted-by":"publisher","first-page":"7108","DOI":"10.1074\/jbc.M009234200","volume":"276","author":"E Butt","year":"2001","unstructured":"Butt E, Immler D, Meyer HE, Kotlyarov A, Laass K, Gaestel M. Heat shock protein 27 is a substrate of cGMP-dependent protein kinase in intact human platelets: phosphorylation-induced actin polymerization caused by HSP27 mutants. J Biol Chem. 2001;276:7108\u201313.","journal-title":"J Biol Chem"},{"key":"7814_CR60","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1021\/pr070134c","volume":"6","author":"SY Huang","year":"2007","unstructured":"Huang SY, Tsai ML, Chen GY, Wu CJ, Chen SH. A systematic MS-based approach for identifying in vitro substrates of PKA and PKG in rat uteri. J Proteome Res. 2007;6:2674\u201384.","journal-title":"J Proteome Res"},{"key":"7814_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0021-9258(18)54111-9","volume":"268","author":"M Zhou","year":"1993","unstructured":"Zhou M, Lambert H, Landry J. Transient activation of a distinct serine protein kinase is responsible for 27-kDa heat shock protein phosphorylation in mitogen-stimulated and heat-shocked cells. J Biol Chem. 1993;268:35\u201343.","journal-title":"J Biol Chem"},{"key":"7814_CR62","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0014-5793(92)81216-9","volume":"313","author":"D Stokoe","year":"1992","unstructured":"Stokoe D, Engel K, Campbell DG, Cohen P, Gaestel M. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett. 1992;313:307\u201313.","journal-title":"FEBS Lett"},{"key":"7814_CR63","first-page":"35","volume":"35","author":"J Saklatvala","year":"1991","unstructured":"Saklatvala J, Guesdon F. Interleukin 1 signal transduction. Agents Actions Suppl. 1991;35:35\u201340.","journal-title":"Agents Actions Suppl"},{"key":"7814_CR64","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.lfs.2004.12.017","volume":"77","author":"K Nakajima","year":"2005","unstructured":"Nakajima K, Hirade K, Ishisaki A, Matsuno H, Suga H, Kanno Y, et al. Akt regulates thrombin-induced HSP27 phosphorylation in aortic smooth muscle cells: function at a point downstream from p38 MAP kinase. Life Sci. 2005;77:96\u2013107.","journal-title":"Life Sci"},{"key":"7814_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mce.2007.02.002","volume":"270","author":"AS Al-Madhoun","year":"2007","unstructured":"Al-Madhoun AS, Chen YX, Haidari L, Rayner K, Gerthoffer W, McBride H, et al. The interaction and cellular localization of HSP27 and ER\u03b2 are modulated by 17\u03b2-estradiol and HSP27 phosphorylation. Mol Cell Endocrinol. 2007;270:33\u201342.","journal-title":"Mol Cell Endocrinol"},{"key":"7814_CR66","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jtherbio.2017.06.004","volume":"69","author":"MK Singh","year":"2017","unstructured":"Singh MK, Sharma B, Tiwari PK. The small heat shock protein Hsp27: Present understanding and future prospects. J Therm Biol. 2017;69:149\u201354.","journal-title":"J Therm Biol"},{"key":"7814_CR67","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1080\/10428194.2017.1296146","volume":"58","author":"M Lucijanic","year":"2017","unstructured":"Lucijanic M, Livun A, Tupek KM, Stoos-Veic T, Aralica G, Gecek I, et al. Heat shock protein 27 (HSP27\/HSPB1) expression is increased in patients with primary and secondary myelofibrosis and may be affecting their survival. Leuk Lymphoma. 2017;58:2497\u2013500.","journal-title":"Leuk Lymphoma"},{"key":"7814_CR68","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nrurol.2013.108","volume":"10","author":"J Ischia","year":"2013","unstructured":"Ischia J, So AI. The role of heat shock proteins in bladder cancer. Nat Rev Urol. 2013;10:386\u201395.","journal-title":"Nat Rev Urol"},{"key":"7814_CR69","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cell.2014.10.024","volume":"159","author":"E Chipumuro","year":"2014","unstructured":"Chipumuro E, Marco E, Christensen CL, Kwiatkowski N, Zhang T, Hatheway CM, et al. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell. 2014;159:1126\u201339.","journal-title":"Cell"},{"key":"7814_CR70","doi-asserted-by":"publisher","first-page":"86312","DOI":"10.18632\/oncotarget.21146","volume":"8","author":"H Wang","year":"2017","unstructured":"Wang H, Hong B, Li X, Deng K, Li H, Yan Lui VW, et al. JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against MYCN-amplified small cell lung cancer. Oncotarget. 2017;8:86312\u201324.","journal-title":"Oncotarget"},{"key":"7814_CR71","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1073\/pnas.1802279115","volume":"115","author":"XY Qin","year":"2018","unstructured":"Qin XY, Suzuki H, Honda M, Okada H, Kaneko S, Inoue I, et al. Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid. Proc Natl Acad Sci USA. 2018;115:4969\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7814_CR72","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1158\/0008-5472.CAN-12-0943","volume":"72","author":"S Hossain","year":"2012","unstructured":"Hossain S, Takatori A, Nakamura Y, Suenaga Y, Kamijo T, Nakagawara A. NLRR1 enhances EGF-mediated MYCN induction in neuroblastoma and accelerates tumor growth in vivo. Cancer Res. 2012;72:4587\u201396.","journal-title":"Cancer Res"},{"key":"7814_CR73","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/1078-0432.CCR-17-1872","volume":"24","author":"W Zhang","year":"2018","unstructured":"Zhang W, Liu B, Wu W, Li L, Broom BM, Basourakos SP, et al. Targeting the MYCN-PARP-DNA damage response pathway in neuroendocrine prostate cancer. Clin Cancer Res. 2018;24:696\u2013707.","journal-title":"Clin Cancer Res"},{"key":"7814_CR74","first-page":"1938","volume":"9","author":"Q Tong","year":"2019","unstructured":"Tong Q, Ouyang S, Chen R, Huang J, Guo L. MYCN-mediated regulation of the HES1 promoter enhances the chemoresistance of small-cell lung cancer by modulating apoptosis. Am J Cancer Res. 2019;9:1938\u201356.","journal-title":"Am J Cancer Res"},{"key":"7814_CR75","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.omto.2022.02.020","volume":"24","author":"S Wu","year":"2022","unstructured":"Wu S, Xu H, Zhang R, Wang X, Yang J, Li X, et al. Circular RNA circLAMA3 inhibits the proliferation of bladder cancer by directly binding an mRNA. Mol Ther Oncolytics. 2022;24:742\u201354.","journal-title":"Mol Ther Oncolytics"},{"key":"7814_CR76","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.canlet.2011.09.008","volume":"313","author":"M Nakashima","year":"2011","unstructured":"Nakashima M, Adachi S, Yasuda I, Yamauchi T, Kawaguchi J, Itani M, et al. Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells. Cancer Lett. 2011;313:218\u201325.","journal-title":"Cancer Lett"},{"key":"7814_CR77","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1158\/1535-7163.MCT-09-0148","volume":"8","author":"Y Matsui","year":"2009","unstructured":"Matsui Y, Hadaschik BA, Fazli L, Andersen RJ, Gleave ME, So AI. Intravesical combination treatment with antisense oligonucleotides targeting heat shock protein-27 and HTI-286 as a novel strategy for high-grade bladder cancer. Mol Cancer Ther. 2009;8:2402\u201311.","journal-title":"Mol Cancer Ther"},{"key":"7814_CR78","doi-asserted-by":"crossref","unstructured":"Abdel-Rahman O, Elsayed Z, Elhalawani H. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. Cochrane Db Syst Rev. 2018;4:CD011746.","DOI":"10.1002\/14651858.CD011746.pub2"},{"key":"7814_CR79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.eururo.2021.09.026","volume":"81","author":"R Cathomas","year":"2022","unstructured":"Cathomas R, Lorch A, Bruins HM, Comp\u00e9rat EM, Cowan NC, Efstathiou JA, et al. The 2021 Updated European association of urology guidelines on metastatic urothelial carcinoma. Eur Urol. 2022;81:95\u2013103.","journal-title":"Eur Urol"},{"key":"7814_CR80","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1158\/0008-5472.CAN-09-4213","volume":"70","author":"D Lindgren","year":"2010","unstructured":"Lindgren D, Frigyesi A, Gudjonsson S, Sj\u00f6dahl G, Hallden C, Chebil G, et al. Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. Cancer Res. 2010;70:3463\u201372.","journal-title":"Cancer Res"},{"key":"7814_CR81","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","volume":"18","author":"G Sj\u00f6dahl","year":"2012","unstructured":"Sj\u00f6dahl G, Lauss M, L\u00f6vgren K, Chebil G, Gudjonsson S, Veerla S, et al. A molecular taxonomy for urothelial carcinoma. Clin Cancer Res. 2012;18:3377\u201386.","journal-title":"Clin Cancer Res"},{"key":"7814_CR82","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Cancer Genome Atlas Research N.","year":"2014","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315\u201322.","journal-title":"Nature"},{"key":"7814_CR83","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25:152\u201365.","journal-title":"Cancer Cell"},{"key":"7814_CR84","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo GW, Cherniack AD, et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2017;171:540.","journal-title":"Cell"},{"key":"7814_CR85","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/path.4886","volume":"242","author":"G Sj\u00f6dahl","year":"2017","unstructured":"Sj\u00f6dahl G, Eriksson P, Liedberg F, H\u00f6glund M. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification. J Pathol. 2017;242:113\u201325.","journal-title":"J Pathol"},{"key":"7814_CR86","doi-asserted-by":"crossref","unstructured":"Guo CC, Bondaruk J, Yao H, Wang ZQ, Zhang L, Lee S, et al. Assessment of luminal and basal phenotypes in bladder cancer. Sci Rep. 2020;10:9743.","DOI":"10.1038\/s41598-020-66747-7"},{"key":"7814_CR87","doi-asserted-by":"crossref","unstructured":"Guo CC, Lee SKY, Lee JG, Chen HQ, Zaleski M, Choi W, et al. Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nat Rev Urol. 2024;21:391-405.","DOI":"10.1038\/s41585-023-00847-7"},{"key":"7814_CR88","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.eururo.2017.03.030","volume":"72","author":"R Seiler","year":"2017","unstructured":"Seiler R, Ashab HA, Erho N, van Rhijn BWG, Winters B, Douglas J, et al. Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy. Eur Urol. 2017;72:544\u201354.","journal-title":"Eur Urol"},{"key":"7814_CR89","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-18-1106","volume":"25","author":"R Seiler","year":"2019","unstructured":"Seiler R, Gibb EA, Wang NQ, Oo HZ, Lam HM, van Kessel KE, et al. Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Clin Cancer Res. 2019;25:5082\u201393.","journal-title":"Clin Cancer Res"},{"key":"7814_CR90","doi-asserted-by":"crossref","unstructured":"Warrick JI, Walter V, Yamashita H, Chung E, Shuman L, Amponsa VO, et al. FOXA1, GATA3 and PPAR\u03b3 cooperate to drive luminal subtype in bladder cancer: a molecular analysis of established human cell lines. Sci Rep. 2016;6:38531.","DOI":"10.1038\/srep38531"},{"key":"7814_CR91","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0021-9258(17)36041-6","volume":"261","author":"HC Cheng","year":"1986","unstructured":"Cheng HC, Kemp BE, Pearson RB, Smith AJ, Misconi L, Vanpatten SM, et al. A potent synthetic peptide inhibitor of the camp-dependent protein-kinase. J Biol Chem. 1986;261:989\u201392.","journal-title":"J Biol Chem"},{"key":"7814_CR92","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/S0021-9258(18)67218-7","volume":"261","author":"DB Glass","year":"1986","unstructured":"Glass DB, Cheng HC, Kemp BE, Walsh DA. Differential and common recognition of the catalytic sites of the Cgmp-dependent and camp-dependent protein-kinases by inhibitory peptides derived from the heat-stable inhibitor protein. J Biol Chem. 1986;261:2166\u201371.","journal-title":"J Biol Chem"},{"key":"7814_CR93","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0021-9258(17)31276-0","volume":"264","author":"RN Day","year":"1989","unstructured":"Day RN, Walder JA, Maurer RAA. Protein-kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene-transcription. J Biol Chem. 1989;264:431\u20136.","journal-title":"J Biol Chem"},{"key":"7814_CR94","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0021-9258(19)39904-1","volume":"265","author":"MK Smith","year":"1990","unstructured":"Smith MK, Colbran RJ, Soderling TR. Specificities of autoinhibitory domain peptides for 4 protein-kinases - implications for intact cell studies of protein-kinase function. J Biol Chem. 1990;265:1837\u201340.","journal-title":"J Biol Chem"},{"key":"7814_CR95","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/iub.2270","volume":"72","author":"L Fei","year":"2020","unstructured":"Fei L, Wang Y. microRNA-495 reduces visceral sensitivity in mice with diarrhea-predominant irritable bowel syndrome through suppression of the PI3K\/AKT signaling pathway via PKIB. IUBMB Life. 2020;72:1468\u201380.","journal-title":"IUBMB Life"},{"key":"7814_CR96","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev.biophys.29.1.291","volume":"29","author":"MA Mart\u00ed-Renom","year":"2000","unstructured":"Mart\u00ed-Renom MA, Stuart AC, Fiser A, S\u00e1nchez R, Melo F, Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Bioph Biom. 2000;29:291\u2013325.","journal-title":"Annu Rev Bioph Biom"},{"key":"7814_CR97","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, Macarthur MW, Moss DS, Thornton JM. Procheck - a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26:283\u201391.","journal-title":"J Appl Crystallogr"},{"key":"7814_CR98","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/prot.10389","volume":"52","author":"R Chen","year":"2003","unstructured":"Chen R, Li L, Weng ZP. ZDOCK: An initial-stage protein-docking algorithm. Proteins. 2003;52:80\u20137.","journal-title":"Proteins"},{"key":"7814_CR99","doi-asserted-by":"crossref","unstructured":"Pierce BG, Hourai Y, Weng ZP. Accelerating protein docking in ZDOCK using an advanced 3D convolution library. Plos One. 2011;6:e24657.","DOI":"10.1371\/journal.pone.0024657"},{"key":"7814_CR100","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/prot.20559","volume":"60","author":"K Wiehe","year":"2005","unstructured":"Wiehe K, Pierce B, Mintseris J, Tong WW, Anderson R, Chen R, et al. ZDOCK and RDOCK performance in CAPRI rounds 3, 4, and 5. Proteins. 2005;60:207\u201313.","journal-title":"Proteins"},{"key":"7814_CR101","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/prot.24432","volume":"81","author":"T Vreven","year":"2013","unstructured":"Vreven T, Pierce BG, Hwang H, Weng ZP. Performance of ZDOCK in CAPRI Rounds 20-26. Proteins. 2013;81:2175\u201382.","journal-title":"Proteins"},{"key":"7814_CR102","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle Mesh Ewald Method. J Chem Phys. 1995;103:8577\u201393.","journal-title":"J Chem Phys"},{"key":"7814_CR103","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: A linear constraint solver for molecular simulations. J Comput Chem. 1997;18:1463\u201372.","journal-title":"J Comput Chem"},{"key":"7814_CR104","doi-asserted-by":"crossref","unstructured":"Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007;126:014101.","DOI":"10.1063\/1.2408420"},{"key":"7814_CR105","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van der Spoel","year":"2005","unstructured":"Van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. GROMACS: Fast, flexible, and free. J Comput Chem. 2005;26:1701\u201318.","journal-title":"J Comput Chem"},{"key":"7814_CR106","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"K Lindorff-Larsen","year":"2010","unstructured":"Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins. 2010;78:1950\u20138.","journal-title":"Proteins"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07814-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07814-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07814-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:09:47Z","timestamp":1751382587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07814-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7814"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07814-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human BLCA tissues were collected after informed consent was obtained from all patients. The study protocol was conducted in accordance with the Declaration of Helsinki and has been approved by the Academic and Ethics Advisory Committee of the Second Affiliated Hospital of Soochow University (Approval No. [JD-LK-2019-104-01]). Animal experiments were conducted according to guidelines approved by the Animal Care and Use Committee of Soochow University. All animal experiments were approved by the Animal Care and Use Committee of Soochow University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"470"}}